Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study-Reference-Cited by-同舟云学术

Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study

Published:2015-06-26 Issue:3 Volume:62 Page:773-783
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

VanWagner Lisa B.¹²,Wilcox Jane E.¹³,Colangelo Laura A.¹,Lloyd-Jones Donald M.¹³,Carr J. Jeffrey⁴,Lima Joao A.⁵,Lewis Cora E.⁶,Rinella Mary E.²,Shah Sanjiv J.³

Affiliation:

1. Departments of Preventive Medicine and Medicine; Northwestern University; Chicago IL

2. Division of Gastroenterology & Hepatology; Northwestern University; Chicago IL

3. Division of Cardiology; Northwestern University; Chicago IL

4. Departments of Radiology; Cardiovascular Medicine and Biomedical Informatics, Vanderbilt University School of Medicine; Nashville TN

5. Departments of Medicine and Radiology; Johns Hopkins University School of Medicine; Baltimore MD

6. Department of Medicine; Division of Preventive Medicine; University of Alabama Birmingham School of Medicine; Birmingham AL

Funder

National Institutes of Health

American Liver Foundation

American Association for the Study of Liver Diseases

Alpha Omega Alpha Honor Medical Society

American Heart Association

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27869/fullpdf

Reference48 articles.

1. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study;Lazo;BMJ,2011

2. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology;Swedberg;Eur Heart J,2005

3. Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease;Ballestri;World J Gastroenterol,2014

4. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease;Villanova;Hepatology,2005

5. Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (NAFLD) by 64-detector multislice computed tomography (MSCT);Akabame;Circ J,2008

Cited by 226 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of disproportionate liver fat with markers of heart failure: The multi-ethnic study of atherosclerosis;American Heart Journal;2024-09

2. Linking abnormal fat distribution with HFpEF and diastolic dysfunction: a systematic review, meta-analysis, and meta-regression of observational studies;Lipids in Health and Disease;2024-08-31

3. Hepatocyte-Specific Casein Kinase 1 Epsilon Ablation Ameliorates Metabolic Dysfunction–Associated Steatohepatitis by Up-Regulating Tumor Necrosis Factor Receptor–Associated Factor 3 in Mice;The American Journal of Pathology;2024-08

4. Non‐alcoholic fatty liver disease increases the risk of biochemical recurrence in high‐grade metastatic prostate cancer patients;Asia-Pacific Journal of Clinical Oncology;2024-07-05

5. A machine learning algorithm for stratification of risk of cardiovascular disease in metabolic dysfunction-associated steatotic liver disease;European Journal of Internal Medicine;2024-07